Skip to main content

Crohn’s Disease

News

IBD is misunderstood

Posted: January 16 2020

Although a 2017 review forecasted that there will be about 2.2 million Americans and about 0.5% of Western Europeans living with IBD in 2025, other reports suggested that the disease is not universally understood. “There are a lot of misunderstandings about IBD,” Paul Feuerstadt MD, FACG, AGAF said. For example, a survey of 409 general practitioners in […]

Read more

News

Diet as therapy for IBD remains hindered by knowledge gaps

Posted: January 16 2020

As patients with Crohn’s disease seek guidance on how to handle their condition, there remains a knowledge gap regarding what, if any, specific dietary recommendations could become a mainstay therapy, according to a presentation at Advances in Inflammatory Bowel Disease 2019. “We don’t have enough definitive research to say that one diet is the right answer for […]

Read more

Research

Infants born to mothers with IBD present with altered gut microbiome

Prenatal and early life bacterial colonisation is thought to play a major role in shaping the immune system.

IBDs, comprising Crohn’s disease (CD) and UC, result from aberrant mucosal immune responses to bacteria in genetically susceptible individuals.1 2 While family history is the strongest risk factor for developing IBD, the genetic loci associated with risk do not fully explain disease heritability.1 IBD affects women during their reproductive years and 25% become pregnant after diagnosis. […]

Read more

Research

Tailoring treatment withdrawal in inflammatory bowel disease

Patients may not relapse over mid-term and those who have relapsed may have benefited from a drug-free period before being treated again.

There is currently no cure for inflammatory bowel disease. Most recent treatments and treatment strategies allow for healing intestinal lesions and maintaining steroid-free remission in a subset of patients. These patients and their doctors often ask themselves whether the treatment could be withdrawn. Several studies in both Crohn’s disease and ulcerative colitis have demonstrated a […]

Read more

Personal Story

I tried 22 different medications before an electrical implant healed my Crohn’s disease

Posted: January 15 2020

When I was in the eighth grade, my life changed forever. I was tap dancing during a play rehearsal and twisted my ankle. It sounds pretty innocuous, right? But what followed was a big shock. At first, the swelling in my ankle seemed normal. After a few weeks my ankle was just as swollen as […]

Read more

News

What to know about Crohn’s and the eyes

Posted: January 9 2020

Common symptoms of Crohn’s disease include cramps, diarrhea, and bloody stool. However, Crohn’s disease can also cause symptoms outside the digestive tract. These include skin complications, problems with joints, and eye disorders. About 10% of people with Crohn’s disease have eye-related symptoms or conditions. Due to the sensitivity of the tissues in the eye, symptoms may occur in this […]

Read more

News

“There’s a lot more work to be done.” – Aida Habtezion

Posted: January 9 2020

In the beginning of her career at Stanford, Habtezion was a fellow in the lab of Eugene Butcher, MD (professor, pathology). “Being in Dr. Eugene Butcher’s lab, learning about leukocyte trafficking, I became interested in why patients with ulcerative colitis would have their disease limited to the colon. Would leukocytes have specific things that targeted them to the […]

Read more

Research

Systemic inflammatory protein profiles distinguish IBS and ulcerative colitis,

Potential links between inflammation and IBS-like symptoms in these patient groups are still unclear.

Patients with ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD) involving the colonic mucosa, may suffer from irritable bowel syndrome (IBS)–like symptoms during periods of remission. It has been suggested that UC patients experiencing IBS-like symptoms during remission suffer from inadequately treated inflammation.1 Likewise, there are reports of systemic and intestinal low-grade immune activation in […]

Read more

News

New Aussie resource to enhance patient understanding of out-of-pocket medical costs

Posted: January 9 2020

A new Medical Costs Transparency website will – for the first time – show Australian patients typical out-of-pocket costs for common treatments and procedures in the private system. Australian patients will be able to search and compare predicted out-of-pocket costs for specific in-hospital treatments delivered in the private setting. Minister for Health, Greg Hunt, said […]

Read more

News

7 recent reports on IBD

Posted: January 7 2020

Inpatient opioids linked with future opioid use in IBD Patients who received intravenous or non-intravenous opioids while in the hospital are more likely to be exposed to opioids after they are discharged, according to study results. Gary R. Lichtenstein, MD, of the Perelman Center for Advanced Medicine at the University of Pennsylvania, and colleagues wrote that […]

Read more